Lundbeck / Tiefenbacher, Ratiopharm, Teva Pharma, Court of Appeal Brussels (Hof van Beroep te Brussel), 14 February 2012

The Court of Appeal partially reversed the Brussels Commercial Court’s decision invalidating Lundbeck’s SPC for escitalopram, to the extent that it had immediate effect.

A summary of this case will be posted on


Leave a Reply

Your email address will not be published. Required fields are marked *